Short answer · Medically reviewed summary · Last updated: 2026-04-08
Trichothiodystrophy (TTD) is a rare genetic disorder characterized by sulfur-deficient brittle hair, often referred to by the clinical abbreviation TTD or historically as IBIDS syndrome when specific systemic features are present. While medical literature uses various descriptive terms based on its complex genetic subtypes, Trichothiodystrophy is the universally accepted clinical name used by global health organizations and specialists today. What are the historical and alternative names for Trichothiodystrophy? Over the decades, Trichothiodystrophy has been described using several names, often derived from the specific constellation of symptoms observed in individual patients.
Trichothiodystrophy (TTD) is a rare genetic disorder characterized by sulfur-deficient brittle hair, often referred to by the clinical abbreviation TTD or historically as IBIDS syndrome when specific systemic features are present. While medical literature uses various descriptive terms based on its complex genetic subtypes, Trichothiodystrophy is the universally accepted clinical name used by global health organizations and specialists today.
Over the decades, Trichothiodystrophy has been described using several names, often derived from the specific constellation of symptoms observed in individual patients. Before the genetic basis of the condition was fully understood, researchers frequently named the disorder based on the clinical features present. The most common synonym you may encounter in medical records or older research papers is IBIDS syndrome, an acronym standing for Ichthyosis, Brittle hair, Impaired intelligence, Decreased fertility, and Short stature. Another historical variation is PIBIDS, which adds Photosensitivity to the list of clinical findings. Because Trichothiodystrophy involves mutations in genes responsible for DNA repair (such as ERCC2, ERCC3, and GTF2H5), it is sometimes categorized within medical literature as a "DNA repair-deficient disorder" or "nucleotide excision repair syndrome."
The multitude of names for Trichothiodystrophy stems from the heterogeneity of the condition. Because the disease can affect multiple body systems—including the skin, nervous system, and skeletal structure—different specialists (such as dermatologists, neurologists, or geneticists) historically emphasized different aspects of the disease. Furthermore, the discovery that Trichothiodystrophy is genetically linked to other conditions, such as Xeroderma Pigmentosum, led to shifting nomenclature as clinicians attempted to group these rare disorders by their underlying molecular mechanism rather than just their outward appearance.
To ensure consistency, major health organizations have standardized the nomenclature. In the Online Mendelian Inheritance in Man (OMIM) database, the condition is categorized under specific gene-related entries, such as #601675. The Orphanet database uses the primary term Trichothiodystrophy to encompass all forms of the disease. Below are the standard identifiers used by medical professionals:
When communicating with healthcare providers or searching for support groups, Trichothiodystrophy is the preferred and most accurate term. Using this name ensures that your records align with current international medical coding. If you are interacting with the 32 members of the DiseaseMaps.org community who are living with this condition, using the term Trichothiodystrophy will help you connect with others who share the same genetic profile and clinical challenges.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always consult with a qualified healthcare professional regarding your specific condition.